Chengdu Kanghong Pharmaceutical Group Co.,Ltd.’s Net Profit Rose 105.6% in 2022
Listen to the full version

Chengdu Kanghong Pharmaceutical Group Co.,Ltd. (成都康弘药业集团股份有限公司) (002773.SZ) reported a net profit of 865.8 million yuan in 2022, up 105.6% year-on-year.
Meanwhile, the company posted 3.4 billion yuan in revenue, down 6% year-on-year.
At the end of the reporting period, it had 7.7 billion yuan in total assets and 813.9 million yuan in total liabilities, with a liability-to-asset ratio of 10.5%.
Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.
Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.
- PODCAST
- MOST POPULAR